GSK (NYSE: GSK) has a new mission and that mission is to go after major medical conditions that have no treatment. The...
Vaccines have less efficacy with COVID-19 variants Key 3CL protease inhibitors shows promise for any COVID-19 variants, and potentially all coronav...
Enrollment Key Metric in Therapeutic Race Philippines EUA Relevant to CytoDyn, not Humanigen Highly Credentialed Humanigen Team Possibility of NAS...
CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...
Developing a vaccine to treat COVID-19 is hands down the best way to play the long term coronavirus stocks. Ultimately a vaccine...
Innovus Pharmaceuticals Inc (OTCMKTS:INNV) is up nearly 14% heading into the US open on Tuesday, as markets anticipate an FDA nod for...